EUVIMEDEUVIMED entdecken
Crossref

P-227: WAGR syndrome with early metabolic dysfunction: the importance of genetic diagnosis and multidisciplinary care

R Dobrovolskiene, E Jasinskiene, R T Preiksa, I Stankute, R Traberg, R Verkauskiene

Hormone Research in Paediatrics · 04.11.2026 · 99 (Supplement_4)

DOI: 10.1159/hrp/adaag020.285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 04.11.2026. Verfasst von R Dobrovolskiene und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

WAGR syndrome is a rare contiguous gene deletion disorder characterized by the classical tetrad: Wilms tumor, aniridia, genitourinary anomalies, and a spectrum of developmental delays. It is caused by a deletion on chromosome 11p13, typically involving critical genes such as WT1 and PAX6.

Objectives

To present a rare clinical case of WAGR syndrome with multisystem involvement, including endocrine and metabolic abnormalities.

Methods

A 4-year-old girl was referred to a pediatric endocrinologist due to rapid weight gain and metabolic disturbances. Her anthropometric measurements were: height 100.2 cm (10th–25th percentile), weight 19 kg (75th–90th percentile), and BMI 18.92 kg/m2 (approaching the 97th percentile). Laboratory evaluation revealed fasting hyperglycemia (up to 5.84 mmol/L) with insulin resistance (HOMA-IR 3.63), and central hypothyroidism (low TSH and low FT4). Previous medical history: she was the first child in the family. Aniridia was diagnosed shortly after birth. At the age of 1.5 years, she was diagnosed with nephroblastoma (Wilms tumor) of the right kidney. Given the suspicion of a rare syndromic condition, the patient was referred for genetic evaluation.

Results

Genetic testing identified a pathogenic heterozygous deletion >7 Mb on chromosome 11p13, encompassing multiple genes including PAX6, WT1, BDNF, FSHB, DCDC1, ELP4, RCN1, HIPK3, and CD44. Haploinsufficiency of WT1, PAX6, and BDNF is considered central to the patient’s phenotype, contributing to tumor predisposition, ocular abnormalities, and neurodevelopmental and metabolic features.

Conclusions

This case highlights the critical role of genetic testing in patients with congenital anomalies and multisystem involvement. WAGR syndrome may also present with endocrine and metabolic disturbances, including obesity, insulin resistance, and hypothyroidism. Early diagnosis and coordinated multidisciplinary management are essential to optimize clinical outcomes.

Zitieren

APA

Dobrovolskiene, R., Jasinskiene, E., Preiksa, R. T., Stankute, I., Traberg, R., & Verkauskiene, R. (2026). P-227: WAGR syndrome with early metabolic dysfunction: the importance of genetic diagnosis and multidisciplinary care. Hormone Research in Paediatrics, 99(Supplement_4). https://doi.org/10.1159/hrp/adaag020.285

Vancouver

Dobrovolskiene R, Jasinskiene E, Preiksa RT, Stankute I, Traberg R, Verkauskiene R. P-227: WAGR syndrome with early metabolic dysfunction: the importance of genetic diagnosis and multidisciplinary care. Hormone Research in Paediatrics. 2026;99(Supplement_4). doi:10.1159/hrp/adaag020.285

BibTeX
@article{Dobrovolskiene2026,
  author = {Dobrovolskiene, R and Jasinskiene, E and Preiksa, R T and Stankute, I and Traberg, R and Verkauskiene, R},
  title = {P-227: WAGR syndrome with early metabolic dysfunction: the importance of genetic diagnosis and multidisciplinary care},
  journal = {Hormone Research in Paediatrics},
  year = {2026},
  volume = {99},
  number = {Supplement_4},
  doi = {10.1159/hrp/adaag020.285}
}
Kostenlos starten →